{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:05:27Z","timestamp":1787169927808,"version":"build-2736575974"},"reference-count":60,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Invention for Innovation (i4i) Innovative Prognostic Test for Early-Stage Cutaneous Melanoma","award":["20993"],"award-info":[{"award-number":["20993"]}]},{"name":"National Institute for Health Research (NIHR) Health Technology Assessment Programme","award":["16\/166\/05"],"award-info":[{"award-number":["16\/166\/05"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,3]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify prognostic models for melanoma survival, recurrence and metastasis among American Joint Committee on Cancer stage I and II patients postsurgery; and evaluate model performance, including overall survival (OS) prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and narrative synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Searched MEDLINE, Embase, CINAHL, Cochrane Library, Science Citation Index and grey literature sources including cancer and guideline websites from 2000 to September 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Included studies on risk prediction models for stage I and II melanoma in adults \u226518 years. Outcomes included OS, recurrence, metastases and model performance. No language or country of publication restrictions were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Two pairs of reviewers independently screened studies, extracted data and assessed the risk of bias using the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies checklist and the Prediction study Risk of Bias Assessment Tool. Heterogeneous predictors prevented statistical synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 28 967 records, 15 studies reporting 20 models were included; 8 (stage I), 2 (stage II), 7 (stages I\u2013II) and 7 (stages not reported), but were clearly applicable to early stages. Clinicopathological predictors per model ranged from 3\u201310. The most common were: ulceration, Breslow thickness\/depth, sociodemographic status and site. Where reported, discriminatory values were \u22650.7. Calibration measures showed good matches between predicted and observed rates. None of the studies assessed clinical usefulness of the models. Risk of bias was high in eight models, unclear in nine and low in three. Seven models were internally and externally cross-validated, six models were externally validated and eight models were internally validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All models are effective in their predictive performance, however the low quality of the evidence raises concern as to whether current follow-up recommendations following surgical treatment is adequate. Future models should incorporate biomarkers for improved accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42018086784.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073306","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T22:30:49Z","timestamp":1695940249000},"page":"e073306","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6193-1365","authenticated-orcid":false,"given":"Tafadzwa Patience","family":"Kunonga","sequence":"first","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P W","family":"Kenny","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Astin","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[{"name":"Biostatistics Research Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Kontogiannis","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diarmuid","family":"Coughlan","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Richmond","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H","family":"Eastaugh","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R","family":"Beyer","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Pearson","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Craig","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Lovat","sequence":"additional","affiliation":[{"name":"Dermatological Sciences, Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"AMLo Bisciences, The Biosphere, Newcastle Helix, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ellis","sequence":"additional","affiliation":[{"name":"Dermatological Sciences, Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"AMLo Bisciences, The Biosphere, Newcastle Helix, Newcastle upon Tyne, UK"},{"name":"Department of Dermatology, South Tees Hospitals NHS FT, Middlesbrough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2025121422303849000_13.9.e073306.1","doi-asserted-by":"crossref","unstructured":"Matthews NH , Li WQ , Qureshi AA , et al . Cutaneous Melanoma: etiology and therapy. In: Ward WH , Farma JM , eds. Epidemiology of melanoma. Brisbane (AU): Codon Publications, 2017. doi:10.15586\/codon.cutaneousmelanoma.2017","DOI":"10.15586\/codon.cutaneousmelanoma.2017"},{"key":"2025121422303849000_13.9.e073306.2","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.canep.2016.02.005","article-title":"The burden of cutaneous Melanoma and status of preventive measures in central and South America","volume":"44 Suppl 1","author":"de Vries","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"2025121422303849000_13.9.e073306.3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CLEP.S99021","article-title":"Stage-specific survival and recurrence in patients with cutaneous malignant Melanoma in Europe - a systematic review of the literature","volume":"8","author":"Svedman","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2025121422303849000_13.9.e073306.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"2025121422303849000_13.9.e073306.5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bjps.2017.05.025","article-title":"Sentinel node biopsy status is strongly predictive of survival in cutaneous Melanoma: extended follow-up of Oxford patients from 1998 to 2014","volume":"70","author":"Thomson","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025121422303849000_13.9.e073306.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1002967"},{"key":"2025121422303849000_13.9.e073306.7","unstructured":"Barbour A , Millward M , Morton R , et al . Clinical practice guidelines for the diagnosis and management of melanoma Sydney: cancer council Australia:clinical guidelines network. 2018 Available: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Melanoma [Accessed 11 Oct 2019]."},{"key":"2025121422303849000_13.9.e073306.8","unstructured":"American Joint Committee on Cancer . AJCC Cancer Staging Manual 8th ed. Chicago: American Joint Committee on Cancer\/Springer, 2017."},{"key":"2025121422303849000_13.9.e073306.9","doi-asserted-by":"crossref","unstructured":"American Joint Committee on Cancer . AJCC Cancer Staging Manual 7th ed. New York, NY: Chicago: American Joint Committee on Cancer, 2010. doi:10.1007\/978-0-387-88441-7","DOI":"10.1007\/978-0-387-88441-7"},{"key":"2025121422303849000_13.9.e073306.10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-301247"},{"key":"2025121422303849000_13.9.e073306.11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0295"},{"key":"2025121422303849000_13.9.e073306.12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/jamadermatol.2013.8890","article-title":"Risk prediction models for incident primary cutaneous melanoma: a systematic review","volume":"150","author":"Vuong","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2025121422303849000_13.9.e073306.13","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17217919","article-title":"Risk prediction models for melanoma: a systematic review on the heterogeneity in model development and validation","volume":"17","author":"Kaiser","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025121422303849000_13.9.e073306.14","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1245\/s10434-016-5212-5","article-title":"Critical assessment of clinical prognostic tools in melanoma","volume":"23","author":"Mahar","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025121422303849000_13.9.e073306.15","unstructured":"Cancer Research UK . Treatment for stage 1 and 2 melanoma 2022, Available: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.nhs.uk\/ipgmedia\/National\/Cancer%20Research%20UK\/assets\/Treatingearly(Stage1)melanoma(CRUK2pages).pdf [Accessed 21 Jun 2022]."},{"key":"2025121422303849000_13.9.e073306.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"2025121422303849000_13.9.e073306.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032844","article-title":"Search filters for finding prognostic and diagnostic prediction studies in medline to enhance systematic reviews","volume":"7","author":"Geersing","year":"2012","journal-title":"PLoS One"},{"key":"2025121422303849000_13.9.e073306.18","article-title":"Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor review","volume":"2019","author":"Hayden","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121422303849000_13.9.e073306.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.03.008"},{"key":"2025121422303849000_13.9.e073306.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"key":"2025121422303849000_13.9.e073306.21","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1376"},{"key":"2025121422303849000_13.9.e073306.22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/nep.13913","article-title":"Appraising prediction research: a guide and meta-review on bias and applicability assessment using the prediction model risk of bias assessment tool (PROBAST)","volume":"26","author":"de Jong","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"2025121422303849000_13.9.e073306.23","unstructured":"Sch\u00fcnemann H , Bro\u017cek J , Guyatt G , et al . GRADE handbook for grading quality of evidence and strength of recommendations 2013, Available: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html [Accessed 18 Dec 2020]."},{"key":"2025121422303849000_13.9.e073306.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"2025121422303849000_13.9.e073306.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1024-4","article-title":"Prognostic survival model for people diagnosed with invasive cutaneous melanoma","volume":"15","author":"Baade","year":"2015","journal-title":"BMC Cancer"},{"key":"2025121422303849000_13.9.e073306.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3622"},{"key":"2025121422303849000_13.9.e073306.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(00)80246-4"},{"key":"2025121422303849000_13.9.e073306.28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.20.02446","article-title":"Development and validation of nomograms to predict local, regional, and distant recurrence in patients with thin (T1) melanomas","volume":"39","author":"El Sharouni","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025121422303849000_13.9.e073306.29","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1245\/s10434-020-08959-9","article-title":"Sentinel node status is the most important prognostic information for clinical stage IIB and IIC melanoma patients","volume":"27","author":"Fonseca","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025121422303849000_13.9.e073306.30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.1463"},{"key":"2025121422303849000_13.9.e073306.31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.015"},{"key":"2025121422303849000_13.9.e073306.32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2340"},{"key":"2025121422303849000_13.9.e073306.33","doi-asserted-by":"crossref","unstructured":"Rosenbaum BE , Schafer C , Han SW , et al . Computer-assisted image analysis demonstrates tumor area and width as Prognostic factors in stage IB Melanoma. Pigment Cell Melanoma Res 2017;30. doi:10.1038\/modpathol.2017.64","DOI":"10.1038\/modpathol.2017.64"},{"key":"2025121422303849000_13.9.e073306.34","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1050-z"},{"key":"2025121422303849000_13.9.e073306.35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10543400701199585","article-title":"An integrated tree-based classification approach to prognostic grouping with application to localized melanoma patients","volume":"17","author":"Tsai","year":"2007","journal-title":"J Biopharm Stat"},{"key":"2025121422303849000_13.9.e073306.36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/bjs.10995","article-title":"Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes","volume":"106","author":"Verver","year":"2019","journal-title":"Br J Surg"},{"key":"2025121422303849000_13.9.e073306.37","doi-asserted-by":"publisher","DOI":"10.1309\/WAVR-560R-NU5E-4Q96"},{"key":"2025121422303849000_13.9.e073306.38","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1002\/cam4.3318","article-title":"Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population\u2010based study","volume":"9","author":"Xiao","year":"2020","journal-title":"Cancer Med"},{"key":"2025121422303849000_13.9.e073306.39","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6080"},{"key":"2025121422303849000_13.9.e073306.40","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5941"},{"key":"2025121422303849000_13.9.e073306.41","doi-asserted-by":"crossref","unstructured":"Steyerberg EW . Clinical prediction models. New York, NY: Springer, 2009. doi:10.1007\/978-0-387-77244-8","DOI":"10.1007\/978-0-387-77244-8"},{"key":"2025121422303849000_13.9.e073306.42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"2025121422303849000_13.9.e073306.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00341-9"},{"key":"2025121422303849000_13.9.e073306.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.06.018"},{"key":"2025121422303849000_13.9.e073306.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.patcog.2015.03.009"},{"key":"2025121422303849000_13.9.e073306.46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejso.2021.11.010","article-title":"Validation of a Clinicopathological and gene expression profile model to identify patients with cutaneous Melanoma where sentinel lymph node biopsy is unnecessary","volume":"48","author":"Johansson","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"2025121422303849000_13.9.e073306.47","doi-asserted-by":"crossref","first-page":"737399","DOI":"10.3389\/fonc.2021.737399","article-title":"Prognosis for cutaneous Melanoma by clinical and pathological profile: a population-based study","volume":"11","author":"Buja","year":"2021","journal-title":"Front Oncol"},{"key":"2025121422303849000_13.9.e073306.48","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c30fb2"},{"key":"2025121422303849000_13.9.e073306.49","doi-asserted-by":"publisher","DOI":"10.3310\/hta25590"},{"key":"2025121422303849000_13.9.e073306.50","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051976","article-title":"Inter-rater agreement in assessing risk of bias in melanoma prediction studies using the prediction model risk of bias assessment tool (PROBAST): results from a controlled experiment on the effect of specific rater training","volume":"12","author":"Kaiser","year":"2023","journal-title":"J Clin Med"},{"key":"2025121422303849000_13.9.e073306.51","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"2025121422303849000_13.9.e073306.52","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare10020238","article-title":"Reporting quality of studies developing and validating melanoma prediction models: an assessment based on the TRIPOD statement","volume":"10","author":"Kaiser","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"2025121422303849000_13.9.e073306.53","unstructured":"Michaelson J . Melanoma Conditional Outcome Calculator 2011, . 2022 Available: http:\/\/lifemath.net\/cancer\/melanoma\/condsurv\/index.php [Accessed 13 Jun 2022]."},{"key":"2025121422303849000_13.9.e073306.54","unstructured":"Michaelson J . Melanoma Outcome Calculator 2011, . 2022 Available: http:\/\/lifemath.net\/cancer\/melanoma\/outcome\/index.php [Accessed 13 Jun 2022]."},{"key":"2025121422303849000_13.9.e073306.55","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-019-0064-7"},{"key":"2025121422303849000_13.9.e073306.56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/phpp.12770","article-title":"Prognostic biomarkers of cutaneous melanoma","volume":"38","author":"Ding","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025121422303849000_13.9.e073306.57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-015-3428-x","article-title":"Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer","volume":"151","author":"Liu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2025121422303849000_13.9.e073306.58","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/bjc.2017.254","article-title":"Tumour mutation status and sites of metastasis in patients with cutaneous melanoma","volume":"117","author":"Adler","year":"2017","journal-title":"Br J Cancer"},{"key":"2025121422303849000_13.9.e073306.59","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jamadermatol.2019.0069","article-title":"Risk factors for lymphatic and hematogenous dissemination in patients with stages I to II cutaneous melanoma","volume":"155","author":"Calomarde-Rees","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2025121422303849000_13.9.e073306.60","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01186-2021","article-title":"Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models","volume":"58","author":"Sadatsafavi","year":"2021","journal-title":"Eur Respir J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:30:49Z","timestamp":1765780249000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,28]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjopen-2023-073306"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073306","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}